Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: Involvement of the TGF-β type II receptor

Molecular Brain Research

Volumn 48, Issue 2, 1997, Pages 315-322

  Ren, Renée Feng ^a   Hawver, David B ^b   Kim, Richard S ^a   Flanders, Kathleen Corey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

amyloid peptide; Alzheimer's disease; hNT cell; Neuroprotection; TGF type II receptor; Transforming growth factor

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE RECEPTOR; NEUROPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEGENERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID BETA-PROTEIN; CELL DIFFERENTIATION; CELL LINE; HUMANS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PHENOTYPE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030812891     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00108-3     Document Type: Article

References (46)

1. Andrews P.W. Retionic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:1984;285-293.
2. Bassing C.H., Yingling J.M., Howe D.J., Wang T., He W.W., Gustafson M.L., Shah P., Donahoe P.K., Wang X.F. A transforming growth factor β type I receptor that signals to activate gene expression. Science. 263:1994;87-89.
3. Chao C., Hug C., Kravitz F.H., Tsang M., Anderson W.R., Peterson P.K. Transforming growth factor β protects human neurons against β-amyloid induced injury. Mol. Chem. Neuropathol. 23:1994;159-169.
4. Chirgwin S., Weatherbee J.A., Tsang M.L., Anderson J.K., Mole J.E., Lucas R., Massagué J. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell. 48:1987;409-415.
5. Cohen P.S., Letterio J.J., Gaetano C., Chan J., Matsumoto, Sporn M.B., Thiele C.J. Induction of transforming growth factor β1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res. 55:1995;2380-2386.
6. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
7. Derynck R., Lindquist P.B., Lee A., Wen D., Tamm J., Graycar J.L., Rhee L., Mason A.J., Miller D.A., Coffey R.J., Moses H.L., Chen E.Y. A new type of transforming growth factor-β, TGF-β3. EMBO J. 7:1988;3737-3743.
8. Falk L.A., De Benedetti F., Lohrey N., Birchenall-Roberts M.C., Ellingsworth L.W., Faltynek C.R., Ruscetti F.W. Induction of TGF-β receptor expression and TGF-β protein production in retinoic acid-treated HL-60 cells: possible TGF-β1-mediated autocrine inhibition. Blood. 77:1991;1248-1255.
9. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-β 1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53:1993;314-332.
10. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., Sporn M.B. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology. 45:1995;1561-1569.
11. Flanders K.C., Ludecke G., Engels S., Cissel D.S., Roberts A.B., Kondaiah P., Lafyatis R., Sporn M.B., Unsicker K. Localization and actions of transforming growth factors-β in the embryonic nervous system. Development. 113:1991;183-191.
12. Franzen P., Ten Dijke P., Ichijo H., Schulz Y.P., Heldin C.H., Miyazono K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell. 75:1993;681-692.
13. Gray C.W., Patel A.J. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes. Mol. Brain Res. 19:1993;251-256.
14. Gross C.E., Bednar M.M., Howard D.B., Sporn M.B. Transforming growth factor-β 1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 24:1993;558-562.
15. Haendler B., Hofer-Warbinek R., Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J. 6:1987;947-950.
16. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
17. Heine U.I., Munoz E.F., Flanders K.C., Ellingsworth L.R., Lam H.-Y.P., Thompson N.L., Roberts A.B., Sporn M.B. Role of transforming growth factor-β in the development of the mouse embryo. J. Cell Biol. 105:1987;2861-2876.
18. Kingsley D.M. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
19. Klempt N.D., Sirimanne E., Gunn A.J., Klempt M., Singh K., William C., Gluckman P.D. Hypoxia-ischemia induces transforming growth factor β1 mRNA in the infant rat brain. Mol. Brain Res. 13:1992;93-101.
20. Lechleider R.J., De Caestecker M., Dehejia A., Polymeropoulos M.H., Roberts A.B. Serine phosphorylation, chromosomal localization, and transforming growth factor-β signal transduction by human bsp-1. J. Biol. Chem. 271:1996;17617-17620.
21. Lin H.Y., Wang X.F., Ng-Eaton E., Weinberg R.A., Lodish H.F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
22. Lippa C.F., Smith T.W., Flanders K.C. Transforming growth factor-β: neuronal and glial expression in CNS degenerative diseases. Neurodegeneration. 4:1995;425-432.
23. Logan A., Frautschy S.A., Gonzalez A.M., Sporn M.B., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
24. Madisen L., Webb N.R., Rose T.M., Marquardt H., Ikeda T., Twardzik D., Seyedin S., Purchio A.F. Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA. 7:1988;1-8.
25. Markowitz S.D., Roberts A.B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:1996;93-102.
26. Massagué J. Receptors for the TGF-β family. Cell. 69:1992;1067-1070.
27. Massagué J., Attisano L., Wrana J.L. The TGF-β family and its composite receptors. Trend Cell Biol. 4:1994;172-178.
28. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P., Sirimanne E., Nikolice K., Gluckman P. Neuronal rescue with transforming growth factor-β1 after hypoxic-ischeamic brain injury. NeuroReport. 5:1994;901-904.
29. Morgan T.E., Nichols N.R., Pasinetti G.M., Finch C.E. TGF-β1 mRNA increases in macrophages/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120:1993;291-301.
30. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell. Biol. 115:1991;1091-1105.
31. Peress N.S., Perillo E. Differential expression of TGF-β1, -2, and -3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54:1995;802-811.
32. Pleasure S.J., Lee V.M.Y. Ntera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:1993;585-602.
33. Pleasure S.J., Page C., Lee V.M.Y. Pure, postmitotic, polarized human neurons derived from Ntera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
34. Prehn J.H.M., Backhauss C., Krieglstein J. Transforming growth factor-β prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neurocortex from ischemic injury in vivo. J. Cerebral Blood Flow Metab. 13:1993;521-525.
35. Prehn J.H.M., Bindokas V.P., Jordan J., Galindo M.F., Ghadge G.D., Roos R.P., Boise L.H., Krajewski T.S., Reed J.C., Miller R.J. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmcol. 49:1996;319-328.
36. Prehn J.H.M., Bindokas V.P., Marcuccilli C.J. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12599-12603.
37. Prehn J.H.M., Peruche B., Unsicker K., Krieglstein J. Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60:1993;1665-1672.
38. Ren R.F., Flanders K.C. Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732:1996;16-24.
39. A.B. Roberts and M.B. Sporn, The transforming growth factors-β, in: M.B. Sporn and A.B. Roberts (Eds.), Handbook of Experimental Pharmacology, Peptide Growth Factors and their Receptors I, Vol. 95, Springer, Heidelberg, Germany, 1990, pp. 419-472.
40. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor-β isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
41. Van der Wal E.A., Gomez-Pinilla F., Cotman C.W. Transforming growth factor-β1 is in plaques in Alzheimer's and Down pathologies. NeuroReport. 4:1993;69-72.
42. Wang X.F., Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., Weinberg R.A. Expression cloning and characterization of the TGF-β type III receptor. Cell. 67:1991;797-805.
43. Wertkin A.M., Turner R.S., Pleasure S.J., Golde T.E., Younkin S.G., Trojanowski J.Q., Lee V.M.Y. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA. 90:1993;9513-9517.
44. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Kaiho M., Wang X.F., Massagué J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell. 71:1992;1014-1993.
45. Wrana J.L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
46. Younkin D.P., Tang C.M., Hardy M., Reddy U.R., Shi Q.Y., Pleasure S.J., Lee V.M.Y., Pleasure D. Inducible expression of neuronal glutamate receptor channels in NT2 human cell line. Proc. Natl. Acad. Sci. USA. 90:1993;2174-2178.